High prevalence of Hepatitis C virus among injection drug users in Zhenjiang, Jiangsu, China

Indian Journal of Virology

Volumn 22, Issue 2, 2011, Pages 77-83

  Wu, Nana ^a   Ge, Qinjuan ^b   Feng, Qingchuan ^a,c   Zhang, Jun ^b   Liu, Xiaoxia ^b   Sun, Caihong ^b   Xu, Yongkang ^b   He, Guangli ^b   Zhang, Chiyu ^a  

^a JIANGSU UNIVERSITY   (China)

^b Zhenjiang Center for Disease Control and Prevention   (China)

^c ZHENGZHOU UNIVERSITY   (China)

Author keywords

Education level; HCV; Injection drug use (IDU); Jiangsu; Middle and high school

Indexed keywords

DIAMORPHINE;

ADULT; ARTICLE; CHINA; CHINESE; CONTROLLED STUDY; DIVORCE; DRUG ABUSE; DRUG USE; FEMALE; HEALTH EDUCATION; HEPATITIS C; HEPATITIS C VIRUS; HIGH SCHOOL GRADUATE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE SCHOOL STUDENT; PREVALENCE; SYPHILIS; VIRUS TRANSMISSION; WIDOW;

EID: 84856301911     PISSN: 09702822     EISSN: 09740120     Source Type: Journal    
DOI: 10.1007/s13337-011-0041-4     Document Type: Article

References (31)

1. Alter MJ. Prevention of spread of hepatitis C. Hepatology. 2002;36:S93-S98. (Pubitemid 35253468)
2. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol. 2007;13:2436-2441. (Pubitemid 46929498)
3. Balogun MA, Laurichesse H, Ramsay ME, Sellwood J, Westmoreland D, Paver WK, et al. Risk factors, clinical features and genotype distribution of diagnosed hepatitis C virus infections: a pilot for a sentinel laboratory-based surveillance. Commun Dis Public Health. 2003;6:34-39.
4. Bao YP, Liu ZM. Systematic review of HIV and HCV infection among drug users in China. Int J STD AIDS. 2009;20:399-405.
5. Bao Y, Liu Z, Lu L. Review of HIV and HCV infection among drug users in China. Curr Opin in Psychiatr. 2010;23:187.
6. Chen YD, Liu MY, Yu WL, Li JQ, Peng M, Dai Q, et al. Hepatitis C virus infections and genotypes in China. Hepatobiliary Pancreat Dis Int. 2002;1:194-201. (Pubitemid 36748201)
7. Dalgard O, Jeansson S, Skaug K, Raknerud N, Bell H. Hepatitis C in the general adult population of Oslo: prevalence and clinical spectrum. Scand J Gastroenterol. 2003;38:864-870. (Pubitemid 37011581)
8. Deng LP, Gui XE, Wang X, Luo JL. A survey of HIV, HBV, HCV, HGV and TTV infections among drug abusers in Hubei Province (in Chinese). Hubei J Prev Med. 2003;14:2.
9. Dore GJ, Law M, MacDonald M, Kaldor JM. Epidemiology of hepatitis C virus infection in Australia. J Clin Virol. 2003;26: 171-184. (Pubitemid 36206602)
10. Elghouzzi MH, Bouchardeau F, Pillonel J, Boiret E, Tirtaine C, Barlet V, et al. Hepatitis C virus: routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors. Vox Sang. 2000;79:138-144.
11. Garten RJ, Lai S, Zhang J, Liu W, Chen J, Vlahov D, et al. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol. 2004;33:182-188. (Pubitemid 38500175)
12. Garten RJ, Zhang J, Lai S, Liu W, Chen J, Yu XF. Coinfection with HIV and hepatitis C virus among injection drug users in southern China. Clin Infect Dis. 2005;41(Suppl 1):S18-S24. (Pubitemid 40867311)
13. Hahn JA, Page-Shafer K, Lum PJ, Ochoa K, Moss AR. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology. 2001;34:180-187. (Pubitemid 32591498)
14. Mele A, Tosti ME, Marzolini A, Moiraghi A, Ragni P, Gallo G, et al. Prevention of hepatitis C in Italy: lessons from surveillance of type-specific acute viral hepatitis. SEIEVA collaborating Group. J Viral Hepat. 2000;7:30-35. (Pubitemid 30139849)
15. Moore A, Herrera G, Nyamongo J, Lackritz E, Granade T, Nahlen B, et al. Estimated risk of HIV transmission by blood transfusion in Kenya. Lancet. 2001;358:657-660. (Pubitemid 32786838)
16. Qian HZ, Schumacher JE, Chen HT, Ruan YH. Injection drug use and HIV/AIDS in China: review of current situation, prevention and policy implications. Harm Reduct J. 2006;3:4.
17. Ray VL, Chaudhary RK, Choudhury N. Transfusion safety in developing countries and the Indian scenario. Dev Biol. 1999;102:195-203.
18. Ruan YH, Hong KX, Liu SZ, He YX, Zhou F, Qin GM, et al. Community-based survey of HCV and HIV coinfection in injection drug abusers in Sichuan Province of China. World J Gastroenterol. 2004;10:1589-1593. (Pubitemid 38786937)
19. Shan H, Wang JX, Ren FR, Zhang YZ, Zhao HY, Gao GJ, et al. Blood banking in China. Lancet. 2002;360:1770-1775. (Pubitemid 35447918)
20. Shang H, Zhong P, Liu J, Han X, Dai D, Zhang M, et al. High prevalence and genetic diversity of HCV among HIV-1 infected people from various high-risk groups in China. PLoS ONE. 2010;5:e10631.
21. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005;5:558-567. (Pubitemid 41196755)
22. Sy T, Jamal MM. Epidemiology of hepatitis C virus (HCV) infection. Int J Med Sci. 2006;3:41-46.
23. Terrault NA. Sexual activity as a risk factor for hepatitis C. Hepatology. 2002;36:S99-S105. (Pubitemid 35253469)
24. Thorpe LE, Ouellet LJ, Levy JR, Williams IT, Monterroso ER. Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999. J Infect Dis. 2000;182:1588-1594.
25. Thorpe LE, Ouellet LJ, Hershow R, Bailey SL, Williams IT, Williamson J, et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol. 2002;155:645-653. (Pubitemid 34246097)
26. Wang NC, Qiao XC, Zhang LF, Liu YP, Wu LP. Seroepidemiology of HCV infection among different populations in Shanxi (in Chinese). Chin Public Health. 2001;17:1.
27. Xia X, Luo J, Dong J, You H, Qian Y, Qian X. Epidemiological survey on the HCV infection among drug users in some areas of Jiangsu (in Chinese). Mod Prev Med. 2007;34:3.
28. Xia X, Luo J, Bai J, Yu R. Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis. Public Health. 2008;122:990-1003.
29. Yang J, Ding JJ, Li YY. Co-infection with HCV and HGV among 107 injection drug users (in Chinese). Chin J Prev Med. 2000;34:1.
30. Zhang C, Yang R, Xia X, Qin S, Dai J, Zhang Z, et al. High prevalence of HIV-1 and hepatitis C virus coinfection among injection drug users in the southeastern region of Yunnan, China. J Acquir Immune Defic Syndr. 2002;29:191-196. (Pubitemid 34164893)
31. Zhang C, Wu N, Liu J, Ge Q, Huang Y, Ren Q, et al. HCV subtype characterization among injection drug users: implication for a crucial role of Zhenjiang in HCV transmission in China. PLoS ONE. 2011;6:e16817.